KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Inovio Pharmaceuticals (INO) Prepaid Assets (2016 - 2025)

Inovio Pharmaceuticals (INO) has disclosed Prepaid Assets for 16 consecutive years, with $2.6 million as the latest value for Q4 2025.

  • Quarterly Prepaid Assets fell 29.75% to $2.6 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $2.6 million through Dec 2025, down 29.75% year-over-year, with the annual reading at $2.6 million for FY2025, 29.75% down from the prior year.
  • Prepaid Assets hit $2.6 million in Q4 2025 for Inovio Pharmaceuticals, down from $3.4 million in the prior quarter.
  • In the past five years, Prepaid Assets ranged from a high of $85.3 million in Q3 2021 to a low of $2.2 million in Q1 2025.
  • Historically, Prepaid Assets has averaged $25.7 million across 5 years, with a median of $5.2 million in 2023.
  • Biggest five-year swings in Prepaid Assets: soared 2302.88% in 2021 and later tumbled 94.26% in 2023.
  • Year by year, Prepaid Assets stood at $38.8 million in 2021, then increased by 29.08% to $50.1 million in 2022, then tumbled by 89.2% to $5.4 million in 2023, then plummeted by 31.35% to $3.7 million in 2024, then dropped by 29.75% to $2.6 million in 2025.
  • Business Quant data shows Prepaid Assets for INO at $2.6 million in Q4 2025, $3.4 million in Q3 2025, and $4.3 million in Q2 2025.